Plasma vasohibin-1 and vasohibin-2 are useful biomarkers in patients with esophageal squamous cell carcinoma.
Miho YamamotoSoji OzawaYamato NinomiyaKazuo KoyanagiJunya OgumaAkihito KazunoHitoshi HaraKentaro YatabeHiroshi KajiwaraNaoya NakamuraYasufumi SatoPublished in: Esophagus : official journal of the Japan Esophageal Society (2020)
In patients with ESCC, high plasma concentrations were associated with poor clinical outcomes for both VASH1 and VASH2. We propose that results indicate that plasma VASH1 and VASH2 are useful biomarkers in patients with ESCC.
Keyphrases